oral noncovalent hemoglobin (HbS) modulator 2:1 binding, high RBC partition.; in Ph. I w/ HV from virtual screening, NMR confirm. and opt. J. Med. Chem., Dec. 24, 2020 Pfizer, Groton, CT / Cambridge, MA